|
 |
OvidrelThis page contains recent news articles, when available, and an overview of Ovidrel but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Ovidrel (when available) Used to treat female infertility, Choriogonadotropin alfa stimulates late follicular maturation and resumption of oocyte meiosis, and initiates rupture of the pre-ovulatory ovarian follicle. Ovidrel is an analogue of Luteinizing Hormone (LH) and binds to the LH/hCG receptor of the granulosa and theca cells of the ovary to effect these changes in the absence of an endogenous LH surge. For treatment of female infertility Mechanism Of Action: Choriogonadotropin alfa binds to the Follicle stimulating hormone receptor which results in ovulation in the absence of sufficient endogenous Luteinizing hormone. News Articles on Choriogonadotropin alfa EMD Serono, Inc. and Nationally Ranked US Hospital Announce Collaboration in ... - Dec 16, 2009 EMD Serono is a leader in reproductive health, with Gonal-f® (follitropin alfa for injection), Luveris® (lutropin alfa for injection) and Ovidrel® Prefilled ... PR Newswire (press release) EMD Serono film contest flags infertility - Nov 9, 2009 EMD Serono's fertility products include recombinant versions of three hormones – Gonal-f, Ovidrel and Luveris – along with Cetrotide, which is used to ... Medical Marketing and Media Fertility Experts Present The Latest Research At Reproductive... - Nov 8, 2008 SC Ovidrel® Can Be Reliably Used for Egg-Cell Donation. "Lower Serum hCG Levels After Ovidrel® Administration Do Not Reflect Compromised Oocyte Maturation ... Medical News Today - Medical News Today (press release) Rebif®, Gonal-f®, Luveris®, Ovidrel®/Ovitrelle®, Serostim®, Saizen®, ... - Jul 3, 2005 Serono is a biotechnology company headquartered in Geneva, Switzerland. The company was founded in 1906 in Italy. A key step in its development was the ... chemie.de Serono Falls As Buyers Fail to Materalize MOVERS MARKETPLACE By … - Jan 25, 2006 In addition to Rebif, Serono's fastest-growing products are the psoriasis medicine Raptiva, the ovulation hormone Ovidrel, the ovulation control hormone ... RedOrbit Fertility Experts Present the Latest Research at Reproductive... - Nov 7, 2008 They found that Ovidrel injection resulted in significantly lower serum hCG levels compared ... Thus, SC Ovidrel can be reliably used for oocyte donation. ... newswise.com Article: FDA approves delivery system for Enbrel[R].(New Products)(Bri... - Jun 1, 2005 FDA has approved the Ovidrel(R) PreFilled Syringe," said Bharat Tewarie, MD, ... Serono expects Ovidrel(R) PreFilled Syringe to be available in November, ... Pay-Per-View - Dermatology Nursing - HighBeam Research Infertility in Women Medications - Infertility in Women Health... - Oct 29, 2007 Ovidrel is the only available genetically modified hCG drug. Ovidrel has fewer side effects at the injection site, and its quality can be better controlled ... New York Times choriogonadotropin alfa Serono marketed, Canada (infertility) Serono ... - Mar 14, 2005 ...choriogonadotropin alfa, human chorionic gonadotropin, hCG, OVIDREL, OVIDRELLE, OVITRELLE, G3G, Ovulation Stimulants, L1X9, All Other Antineoplastics, ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Press Release: Unique Three-Year Data Demonstrating Long-Term … - May 5, 2008 Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R). In addition to being the world leader in ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: 73 Per Cent of Moderate-to-Severe Psoriasis Patients … - May 23, 2005 Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R). In addition to being the world leader in ... Pay-Per-View - PR Newswire Europe - HighBeam Research Factiva Search - Mar 15, 2006 Determination of regulatory review period for purposes of patent extension: Ovidrel. 15 March, 2006 Federal Register ... Pay-Per-View - Federal Register - Factiva, from Dow Jones Serono Announces Formal Conclusion of Serostim Settlement. - Dec 15, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... Free with registration - PR Newswire - AccessMyLibrary.com Company Profile Report - Mar 29, 2008 Merck Serono Ovidrel/Ovidrel Pre-Filled Syringe (Choriogonadotropin Alfa); Merck Serono Luveris (Lutropin alfa). Ovulation Stimulating Agents ... $50.00 - Revere Reports - Revere Company Profile Report - Mar 1, 2008 Ovidrel/Ovidrel Pre-Filled Syringe (Choriogonadotropin Alfa); Luveris (Lutropin alfa). Ovulation Stimulating Agents. Products: ... $50.00 - Revere Reports - Revere Press Release: Results From IMPROVE Study Show Therapeutic Effect of … - Sep 22, 2008 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/ Ovitrelle ... PR Newswire Europe. Article: Merck Serono Named as ... Pay-Per-View - PR Newswire Europe - HighBeam Research FDA DRUG APPROVALS Pictures from December 30, 2007 | HighBeam … - Dec 30, 2007 Ovidrel Choriogonadotropin alfa for injection SERONO Recombinant hCG with new fertility indication, subcutaneous administration The FDA has approved a new ... Pay-Per-View - AP Images - HighBeam Research Serono falls as buyers fail to materalizeMOVERSMARKETPLACE by … - Jan 25, 2006 In addition to Rebif, Serono's fastest-growing products are the psoriasis medicine Raptiva, the ovulation hormone Ovidrel, the ovulation control hormone ... Pay-Per-View - International Herald Tribune - HighBeam Research Female infertility - Jan 11, 2008 Human chorionic gonadotropin, or HCG, (Ovidrel, Pregnyl). Used in combination with clomiphene, hMG and FSH, this drug stimulates the follicle to release its ... CNN International SUS não é obrigado a dar tratamento para infertilidade - Jan 11, 2007 é portadora de infertilidade feminina associada a anovulação e que necessitaria de tratamento contínuo com o uso dos medicamentos serofene e ovidrel. ... Último Segundo Serono Completes Second Phase III Trial of Its Proprietary Recombinant... - Jan 9, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... RedOrbit Merck Serono SA to Voluntarily Delist and Deregister its Bearer... - Apr 5, 2007 The Company is the world leader in reproductive health, with Gonal-f(R), Luveris(R) and Ovidrel(R)/Ovitrelle(R). It has strong market positions in neurology ... Free with registration - PR Newswire - AccessMyLibrary.com Serono's Board of Directors to Propose an Increase in Authorized... - Mar 31, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... Free with registration - PR Newswire - AccessMyLibrary.com Discontinuation Of Onercept In Moderate-To-Severe Psoriasis And … - Apr 9, 2005 The Company has eight biotechnology products, Rebif(reg), Gonal-f(reg), Luveris(reg), Ovidrel(reg)/Ovitrelle(reg), Serostim(reg), Saizen(reg), Zorbtive(reg) ... Medical News Today - Medical News Today (press release) Merck Serono Launches Easypod(R), First Electronic Growth Hormone … - Jan 30, 2007 The Company is the world leader in reproductive health, with Gonal-f(R), Luveris(R) and Ovidrel(R)/Ovitrelle(R). It has strong market positions in neurology ... RedOrbit Study Shows Patient Preference for Gonal-f(R) RFF Pen to Treat... - Sep 25, 2006 Gonal-f(R) (follitropin alfa for injection), Luveris(R) (lutropin alfa for injection), Ovidrel(R) Prefilled Syringe (choriogonadotropin alfa injection), ... Free with registration - PR Newswire - AccessMyLibrary.com Merck Serono Completes Patient Enrollment in CLARITY Phase III... - Jan 16, 2007 The Company is the world leader in reproductive health, with Gonal-f(R), Luveris(R) and Ovidrel(R)/Ovitrelle(R). It has strong market positions in neurology ... Free with registration - PR Newswire - AccessMyLibrary.com BioMarin And Serono Form Strategic ALLIANCE for the Development and … - May 16, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... Free with registration - PR Newswire - AccessMyLibrary.com ZymoGenetics and Serono Present Positive Results of TACI-Ig Phase 1b ... - Jun 26, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... Free with registration - PR Newswire - AccessMyLibrary.com EMD Serono Launches MS LifeLines Access Made Simple, a Program … - Jul 2, 2007 ...(follitropin alpha for injection), Luveris(R) (lutropin alfa for injection) and Ovidrel(R) Prefilled Syringe (choriogonadotropin alpha injection). ... Free with registration - PR Newswire - AccessMyLibrary.com Onercept in moderate-to-severe psoriasis - Apr 6, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... Free with registration - PR Newswire - AccessMyLibrary.com Serono Announces Initiation of the Reflex Trial to Evaluate New … - Dec 12, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... RedOrbit Merck KGaA Acquires Majority Shareholding in Serono SA - Jan 5, 2007 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... Genetic Engineering News - Genetic Engineering News (press release) Got IUI? How many attempts before succeeding? - Sep 28, 2008 I am doing all that on my natural cycle, with just one injection of Ovidrel (trigger) 36 hours prior to IUI. My doctor told me that there's a 15% chance per ... pregnancyandbaby.com Serono and Rigel Sign Agreement to Develop and Commercialize Aurora … - Oct 25, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... Free with registration - PR Newswire - AccessMyLibrary.com ZymoGenetics and Serono Begin Phase 2 Clinical Trial With Atacicept... - Dec 20, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... Free with registration - PR Newswire - AccessMyLibrary.com ViaCell Announces ViaCyte Collaboration with EMD Serono, Inc. - Sep 4, 2007 In addition, EMD Serono has agreed to provide certain quantities of two of its products, Gonal-f(R) RFF Pen (follitropin alfa injection) and Ovidrel(R) ... Genetic Engineering News - Genetic Engineering News (press release) Is There Change Ahead for the Female Infertility Market? Understand … - Sep 22, 2008 ...for infertility: clomiphene citrate, follicle-stimulating hormones, human menopausal hormones, Schering-Plough's Ganirelix, Merck Serono's Ovidrel. ... RedOrbit Serono and Newron announce global development and … - Oct 16, 2006 The Company has eight biotechnology products, Rebif(r), Gonal-f(r), Luveris(r), Ovidrel(r)/Ovitrelle(r), Serostim(r), Saizen(r), Zorbtive(tm) and Raptiva(r) ... pressrelations.de Serono Announces Major Milestone in Identifying the Genes Involved in... - Mar 17, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... Free with registration - PR Newswire - AccessMyLibrary.com Merck Serono Confirms Previously Announced 2006 Figures. - Mar 21, 2007 The Company is the world leader in reproductive health, with Gonal-f(R), Luveris(R) and Ovidrel(R)/Ovitrelle(R). It has strong market positions in neurology ... Free with registration - PR Newswire - AccessMyLibrary.com Is There Still Hope After 40? - Aug 24, 2005 A human chorionic gonadotropin (hCG) (Profasi, Novarel, Pregnyl, Ovidrel), a medication used to induce a follicle to release its egg, was given to patients ... Fertility Neighborhood Phase III Trial Of Oral Cladribine, A Novel Investigational Therapy... - May 5, 2006 Gonal-f(R) (follitropin alfa for injection), Luveris(R) (lutropin alfa), Ovidrel PreFilled Syringe(R)/Ovitrelle(R) (choriogonadotropin alfa injection), ... Medical News Today - Medical News Today (press release) Squeeze Out of Merck Serono Shares Successfully Completed - Jul 18, 2007 The Company is the world leader in reproductive health, with Gonal-f(R), Luveris(R), Pergoveris(R) and Ovidrel(R)/Ovitrelle(R). ... prnewswire.com Serono and NovImmune to Collaborate in Development of Two Novel … - May 17, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... Free with registration - PR Newswire - AccessMyLibrary.com Merck Serono is Launched. - Jan 8, 2007 The Company is the world leader in reproductive health, with Gonal-f(R), Luveris(R) and Ovidrel(R)/Ovitrelle(R). It has strong market positions in neurology ... Free with registration - PR Newswire - AccessMyLibrary.com Serono: Publication of Interests (Art. 21 LBVM [Swiss Stock Market... - Sep 25, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... Free with registration - PR Newswire - AccessMyLibrary.com Serono and Genmab Sign Worldwide Agreement to Develop and … - May 2, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... Free with registration - PR Newswire - AccessMyLibrary.com Merck Initiates Squeeze Out Procedure for Shares of Merck Serono SA - Mar 21, 2007 The Company is the world leader in reproductive health, with Gonal-f(R), Luveris(R) and Ovidrel(R)/Ovitrelle(R). It has strong market positions in neurology ... Free with registration - PR Newswire - AccessMyLibrary.com Merck KGaA: European Antitrust Authorities Clear Acquisition of Serono - Dec 17, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel (R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... Genetic Engineering News - Genetic Engineering News (press release) Data and Safety Monitoring Board Recommends Discontinuation of … - Oct 3, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... Free with registration - Business Wire - AccessMyLibrary.com Squeeze Out of Merck Serono Shares Successfully Completed - Jul 6, 2007 The Company is the world leader in reproductive health, with Gonal-f(R), Luveris(R), Pergoveris(R) and Ovidrel(R)/Ovitrelle. Genetic Engineering News - Genetic Engineering News (press release) Serono Announces New Appointments to its Executive Management … - May 9, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... Free with registration - PR Newswire - AccessMyLibrary.com Serono Announces the Availability of Saizen(R) for Adult Growth … - Jan 10, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-F(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... RedOrbit European Commission Approves Revision of Therapeutic Indication for … - Jul 10, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... Free with registration - PR Newswire - AccessMyLibrary.com Immune Response to Influenza Vaccine is Maintained in MS Patients … - Nov 9, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... Free with registration - PR Newswire - AccessMyLibrary.com Serono and IVAX to Initiate Phase III Clinical Trial of Mylinax(R) in... - Jan 11, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-F(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... Free with registration - PR Newswire - AccessMyLibrary.com Good 3-Year Results For Psoriasis Patients On Continuous Raptiva … - May 29, 2005 The Company has eight biotechnology products, Rebif , Gonal-f , Luveris , Ovidrel /Ovitrelle , Serostim , Saizen , Zorbtive and Raptiva . ... Medical News Today - Medical News Today (press release) Netherlands Corporate News - Serono presenteert succesverhaal over … - Sep 30, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Multiple Sclerosis - New Rebif(R) Formulation Submitted In USA And … - Apr 10, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(R) and Raptiva(R). ... Medical News Today - Medical News Today (press release) Serono Announces Termination of Discussions Concerning a Sale of the ... - Apr 10, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... Free with registration - PR Newswire - AccessMyLibrary.com Serono Announces Significant Advances in Identifying Most Viable … - Oct 17, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... Free with registration - PR Newswire - AccessMyLibrary.com Serono Delivers Strong Adjusted* Net Income of $183.5m in Third... - Oct 19, 2006 Global sales of supporting products (Ovidrel(R), Cetrotide(R), Crinone(R) and Luveris(R)) were up 11.5%, or 9.5% in local currencies to $21.9m (Q3 2005: ... Free with registration - PR Newswire - AccessMyLibrary.com Serono to Discuss Application Front Ends' Role in Successful Domino … - Jan 26, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-F(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... RedOrbit Serono Welcomes Positive Ratings From Credit Agencies. - Jul 13, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... Free with registration - PR Newswire - AccessMyLibrary.com Multiple Sclerosis - Serono Announces Major Milestone in Identifying... - Mar 29, 2005 The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel®/Ovitrelle®, Serostim®, Saizen®, Zorbtive™ and Raptiva®. ... i-newswire.com Multiple Sclerosis - Serono Announces Major Milestone in Identifying... - Mar 28, 2005 The Company has eight biotechnology products, Rebif®, Gonal-f®, Luveris®, Ovidrel®/Ovitrelle®, Serostim®, Saizen®, Zorbtive™ and Raptiva®. ... Medical News Today - Medical News Today (press release) Ministra Ellen Gracie desobriga Goiás de fornecer gratuitamente … - Jul 24, 2007 ...desobrigando o estado de Goiás a fornecer os medicamentos Synarel, Gonal e Ovidrel para uma paciente portadora de infertilidade feminina. ... Âmbito Jurídico - Âmbito Jurídico (Assinatura) Multiple Sclerosis; US FDA approves drug delivery system for interfero... - Jan 17, 2005 Serono is a biotechnology company that has 7 recombinant products, Rebif, Gonal-F(R), Luveris, Ovidrel(/Ovitrelle, Serostim, Saizen and Zorbtive. ... Pay-Per-View - Pain & Central Nervous System Week - Factiva, from Dow Jones Goldman Sachs Retained to Explore Strategic Alternatives. - Nov 8, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... $4.95 - PR Newswire - ECNext Serono Submits New Formulation of Rebif(R) for Approval in the United... - Apr 4, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... $4.95 - PR Newswire - ECNext Finance; Neurology-focused biotechnology company reports strong full-... - Mar 1, 2005 Serono's core reproductive health portfolio consisting of 3 recombinant hormones (Gonal-f, Ovidrel/Ovitrelle, Luveris) and 2 complementary products ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Serono Delivers Second Quarter EPS of $12.92, Up 25.2% on Adjusted(1 … - Jul 26, 2006 Global sales of supporting products (Ovidrel(R), Cetrotide(R), Crinone(R) and Luveris(R)) were up 6.9%, or 7.5% in local currencies to $23.8m (Q2 2005: ... $4.95 - PR Newswire - ECNext Multiple Sclerosis; US FDA approves drug delivery system for interfero... - Jan 21, 2005 Serono is a biotechnology company that has 7 recombinant products, Rebif, Gonal-F(R), Luveris, Ovidrel(/Ovitrelle, Serostim, Saizen and Zorbtive. ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Serono International SA Patient enrollment in phase 3 trial of... - Feb 23, 2005 Serono has 8 biotechnology products: Rebif, Gonal-F, Luveris, Ovidrel/Ovitrelle, Serostim, Saizen, Zorbtive and Raptiva. The company's focus is on neurology ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones HIV/AIDS Therapy; Patient enrollment in phase 3 trial of somatropin … - Feb 27, 2005 Serono has 8 biotechnology products: Rebif, Gonal-F, Luveris, Ovidrel/Ovitrelle, Serostim, Saizen, Zorbtive and Raptiva. The company's focus is on neurology ... Pay-Per-View - Medical Letter on the CDC & FDA - Factiva, from Dow Jones Merger and Acquisition Scenario - Aug 19, 2006 Serono markets eight biotechnology products: Rebif, Gonal-f, Saizen, Serostim, Raptiva, Ovidrel, Luveris and Zorbtive. All of the Company's recombinant ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Dec 16, 2006 Serono markets eight biotechnology products: Rebif, Gonal-f, Saizen, Serostim, Raptiva, Ovidrel, Luveris and Zorbtive. All of the Company's recombinant ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - May 13, 2006 Serono markets eight biotechnology products: Rebif, Gonal-f, Saizen, Serostim, Raptiva, Ovidrel, Luveris and Zorbtive. All of the Company's recombinant ... $250.00 - Revere Reports - Revere Morning Alert for Merck Serono SA - Feb 27, 2007 The company offers Gonal-f for the treatment of ovulation disorders; Ovidrel/Ovitrelle to induce final maturation of ovarian follicles and to trigger ... $4.95 - M2 Presswire - ECNext Business Update; Serono's controlling Bertarelli family terminates … - May 10, 2006 Serono, a global biotechnology company, has eight products: Rebif, Gonalf, Luveris, Ovidrel/Ovitrelle, Serostim, Saizen, Zorbtive and Raptiva. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Finance; Neurology-focused biotechnology company reports strong full-... - Mar 5, 2005 Serono's core reproductive health portfolio consisting of 3 recombinant hormones (Gonal-f, Ovidrel/Ovitrelle, Luveris) and 2 complementary products ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Serono Shareholders Approve Resolutions at Annual General Meeting. - Apr 26, 2005 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R)/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and Raptiva(R) ... $4.95 - PR Newswire - ECNext Press Release: Merck Serono Confirms Previously Announced 2006 … - Mar 21, 2007 The Company is the world leader in reproductive health, with Gonal-f(R), Luveris(R) and Ovidrel(R)/Ovitrelle(R). It has strong market positions in neurology ... Pay-Per-View - PR Newswire - HighBeam Research Merger and Acquisition Scenario - Apr 15, 2006 Serono markets eight biotechnology products: Rebif, Gonal-f, Saizen, Serostim, Raptiva, Ovidrel, Luveris and Zorbtive. All of the Company's recombinant ... $250.00 - Revere Reports - Revere Multiple Sclerosis; US FDA gives fast track status to Serono's oral … - Oct 16, 2006 Serono is a biotechnology with eight products: Rebif, Gonal-f, Luveris, Ovidrel/Ovitrelle, Serostim, Saizen, Zorbtive, and Raptiva. ... Pay-Per-View - Biotech Business Week - Factiva, from Dow Jones Merger and Acquisition Scenario - Nov 25, 2006 Serono markets eight biotechnology products: Rebif, Gonal-f, Saizen, Serostim, Raptiva, Ovidrel, Luveris and Zorbtive. All of the Company's recombinant ... $250.00 - Revere Reports - Revere Brooke Shields Lends Her Support to Encourage Women to Take Action … - Nov 3, 2005 The Company has seven recombinant products, Rebif(R) (interferon beta-1a), Gonal-f(R) (follitropin alfa for injection), Luveris(R) (lutropin alfa), Ovidrel ... $4.95 - PR Newswire - ECNext Multiple Sclerosis; US FDA approves drug delivery system for interfero... - Jan 23, 2005 Serono is a biotechnology company that has 7 recombinant products, Rebif, Gonal-F(R), Luveris, Ovidrel(/Ovitrelle, Serostim, Saizen and Zorbtive. ... Pay-Per-View - Medical Devices & Surgical Technology... - Factiva, from Dow Jones Merger and Acquisition Scenario - Dec 16, 2006 Serono markets eight biotechnology products: Rebif, Gonal-f, Saizen, Serostim, Raptiva, Ovidrel, Luveris and Zorbtive. All of the Company's recombinant ... $250.00 - Revere Reports - Revere Press Release: Morning Alert for Merck Serono SA - M2 Presswire | … - Feb 27, 2007 The company offers Gonal-f for the treatment of ovulation disorders; Ovidrel/Ovitrelle to induce final maturation of ovarian follicles and to trigger ... Pay-Per-View - M2 Presswire - HighBeam Research Multiple Sclerosis; US FDA gives fast track status to Serono's oral … - Oct 20, 2006 Serono is a biotechnology with eight products: Rebif, Gonal-f, Luveris, Ovidrel/Ovitrelle, Serostim, Saizen, Zorbtive, and Raptiva. ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Merger and Acquisition Scenario - Nov 4, 2006 Serono markets eight biotechnology products: Rebif, Gonal-f, Saizen, Serostim, Raptiva, Ovidrel, Luveris and Zorbtive. All of the Company's recombinant ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Sep 2, 2006 Serono markets eight biotechnology products: Rebif, Gonal-f, Saizen, Serostim, Raptiva, Ovidrel, Luveris and Zorbtive. All of the Company's recombinant ... $250.00 - Revere Reports - Revere Press Release: Naked Short Web Site announces CRYO, SRA, HEM, … - Aug 5, 2005 The company offers Gonal-f for the treatment of patients suffering from ovulation disorders; Ovidrel/Ovitrelle to induce final maturation of ovarian ... Pay-Per-View - M2 Presswire - HighBeam Research Press Release: Serono: Publication of Interests (Art. 21 LBVM [Swiss ... - Sep 25, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... Pay-Per-View - PR Newswire - HighBeam Research Serono Shareholders Approve Resolutions at Annual General Meeting. - Apr 25, 2006 The Company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R) /Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... $4.95 - PR Newswire - ECNext Merger and Acquisition Scenario - Apr 7, 2007 The Company markets eight biotechnology products: Rebif, Gonal-f, Saizen, Serostim, Raptiva, Ovidrel, Luveris and Zorbtive. All of the Company's recombinant ... $250.00 - Revere Reports - Revere SERONO'S GONAL-F APPROVED IN JAPAN FOR HYPOGONADISM. - Mar 1, 2006 The company has eight biotechnology products, Rebif(R), Gonal-f(R), Luveris(R), Ovidrel(R )/Ovitrelle(R), Serostim(R), Saizen(R), Zorbtive(TM) and ... $4.95 - Worldwide Biotech - ECNext Merger and Acquisition Scenario - Sep 9, 2006 Serono markets eight biotechnology products: Rebif, Gonal-f, Saizen, Serostim, Raptiva, Ovidrel, Luveris and Zorbtive. All of the Company's recombinant ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Mar 10, 2007 The Company markets eight biotechnology products: Rebif, Gonal-f, Saizen, Serostim, Raptiva, Ovidrel, Luveris and Zorbtive. All of the Company's recombinant ... $250.00 - Revere Reports - Revere PAL, PLAY, SPAB, SRA, CDNR, ORTN have also been added to naked … - Jul 21, 2005 The company offers Gonal-f for the treatment of patients suffering from ovulation disorders; Ovidrel/Ovitrelle to induce final maturation of ovarian ... $4.95 - M2 Presswire - ECNext Brand Names/Synonyms: Ovidrel is also known by the following brand names and/or synonymsChoriogonadotropin beta chain precursor;Chorionic gonadotrophin beta subunit;CG-beta; Ovidrel (Serono SA); Pregnyl (Organon); Novarel (Ferring); Profasi (Serono) Drug Category: Ovidrel is categorized under the following by the FDA: Fertility Agents; gonadotropins (68:18.00) Dosage Forms: SOLUTION Absorption: Not Available Interactions: Not Available Chemical IUPAC Name: Human chorionic gonadotropin |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |